Latest News & Updates
The impact of RAI on long-term outcomes, potential combination strategies, molecular profiling, and novel therapeutics for patients with thyroid cancer were among some of the topics highlighted at the 2014 ATA Annual Meeting.
Molecular profiling has revealed several tumor markers that could be utilized as therapeutic targets for patients with small cell lung cancer (SCLC) or lung neuroendocrine tumors (NETs).
A new study suggests a knowledge gap in Primary Care Providers' familiarity with screening guidelines could also be a barrier to successful implementation.
Biopsies were found to be the most costly tool used in lung cancer diagnosis, and may be performed too frequently based on negative test results and adverse events.
New data being presented at the 84th Annual Meeting of the American Thyroid Association show promise for two molecular tests that help identify indeterminate thyroid nodules as either benign or malignant.
Latest Peer Exchange Discussions
In this segment, Primo N. Lara, Jr, MD; Benjamin P. Levy, MD; and Jyoti D. Patel, MD, discuss the current treatment landscape for patients with non-small cell lung cancer, including the use of chemotherapy and targeted therapy. View Now
Brian Rini, MD, and Janice Dutcher, MD, discuss the role of checkpoint inhibitors in the treatment of renal cell carcinoma. View Now
Drs Michael Williams, Kenneth Kernen, Raoul Concepcion, and Phillippa Cheetham discuss the use of sipuleucel-T in patients with castration-resistant prostate cancer. View Now
Most Popular Right Now
Online CME Activities